Inhibitor clinical burden of disease: a comparative analysis of the CHESS data

BACKGROUND: Patients with hemophilia and inhibitors generally face greater disease burden compared to patients without inhibitors. While raising awareness of relative burden may improve the standard of care for patients with inhibitors, comparative data are sparse. Analyzing data drawn from the Cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Oladapo, Abiola O., Lu, Mei, Walsh, Shaun, O’Hara, Jamie, Kauf, Teresa L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230298/
https://www.ncbi.nlm.nih.gov/pubmed/30413215
http://dx.doi.org/10.1186/s13023-018-0929-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230298/
https://www.ncbi.nlm.nih.gov/pubmed/30413215
http://dx.doi.org/10.1186/s13023-018-0929-9

Ejemplares similares